NRXPW NRX Pharmaceuticals, Inc.

BEARISH Impact: 8/10 25-NSE
Horizon immediate Filed May 22, 2026 Processed 23d 12h ago SEC 0001354457-26-000493
Notable filing: 25-NSE
Latest settled — T+5d
NRXPW ▲ 0.00% at T+5d
SHORT call ✗ call lost 0.00% · α vs SPY +1.21% · entry $0.0142 → $0.0142
Next anchor: T+20d in 8d
Entry anchored
May 22, 2026
via day open
T+1d
0.00%
call 0.00% · α +0.01%
$0.0142
settled 20d ago
T+5d
0.00%
call 0.00% · α +1.21%
$0.0142
settled 14d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Nasdaq filed a Form 25-NSE to remove from listing and deregister the warrants (NRXPW) of NRX Pharmaceuticals, Inc., effective May 22, 2026, under SEC Rule 12d2-2(a)(2) (matured, redeemed, or retired securities). This is a terminal event for the warrant security, eliminating any remaining trading value or conversion optionality.

Actionable Insight

Holders of NRXPW warrants should expect zero residual value post-delisting. Monitor for any final redemption payment from the company, but the filing indicates the securities are matured/retired. No further trading on Nasdaq.

Key Facts

  • Nasdaq filed Form 25-NSE to delist NRXPW warrants effective May 22, 2026.
  • Delisting is under Rule 12d2-2(a)(2) for matured, redeemed, or retired securities.
  • The warrant security will no longer trade on Nasdaq or be registered under the Exchange Act.
  • No financial terms or redemption price are disclosed in the filing.

Financial Impact

Warrant holders lose all trading liquidity and registration; the security is effectively extinguished. No redemption amount stated.

dilutionliquidity

Risk Factors

  • Complete loss of warrant value if no redemption proceeds are paid.
  • No further public market for the warrants; any residual claims must be pursued directly with the issuer.
  • Potential for related common stock (NRXP) to face continued operational or listing challenges.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-000493
Document: 0001354457-26-000493-index-headers.html0001354457-26-000493
Document: 0001354457-26-000493-index.html0001354457-26-000493
Document: 0001354457-26-000493.txt0001354457-26-000493
4 reports for NRXPW
Performance horizon
Filters
Rows
Reports for NRXPW — sortable, filterable
Type Now
Jun 4, 2026
10d ago
8-K
BEARISH ★ 6/10
awaiting T+5
Jun 3, 2026
11d ago
424B5
BEARISH ★ 6/10
awaiting T+5
Jun 2, 2026
12d ago
424B5
BEARISH ★ 6/10
awaiting T+5
May 22, 2026
23d ago
25-NSE
BEARISH ★ 8/10
$0.0142 $0.0142· 0.00%▲ +1.21%
Showing 4 of 4

US Market Status

Market Closed — Opens in 4h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access